Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Non-Randomized, Phase II Trial To Assess Focal Liver Lesion Detection Using Definity-Enhanced Ultrasound Imaging

NCT00162058 is registered in ClinicalTrials.gov with Lantheus Medical Imaging as lead sponsor.

NCT NCT00162058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00162058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Non-Randomized, Phase II Trial To Assess Focal Liver Lesion Detection Using Definity-Enhanced Ultrasound Imaging
Lead sponsor
Lantheus Medical Imaging
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2004
Completion date
April 30, 2006
Enrollment
80
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver disease